MAPK1 and breast carcinoma: In breast cancer cells, SIRT1 was found to deacetylase mitogen-activated protein kinase 1 (MAP2K1), leading to inactivation of the MEK/ERK cell signaling pathway and reduction in FOXM1 protein.